{"id":"W2589788830","doi":"10.1002/ajh.24693","title":"A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR‐CD) for untreated low‐grade non‐Hodgkin lymphoma requiring therapy","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Celgene; Sanofi; Eli Lilly and Company; Amgen","keywords":"Medicine; Lenalidomide; Rituximab; Internal medicine; Follicular lymphoma; Gastroenterology; Cyclophosphamide; Lymphoplasmacytic Lymphoma; Dexamethasone; Lymphoma; Waldenstrom macroglobulinemia; Macroglobulinemia; Marginal zone B-cell lymphoma; Surgery; Oncology; Multiple myeloma; Chemotherapy; Immunology; B cell; Marginal zone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002977044,0.001277375,0.001784921,0.0004276406,0.0005214,0.0009725365,0.000992364,0.001161472,0.003256131],"category_scores_gemma":[0.001304181,0.0007310117,0.0009851927,0.0003614743,0.001003729,0.0007653831,0.0003262768,0.00323224,0.0006289096],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008816666,"about_ca_system_score_gemma":0.001749317,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009896071,"about_ca_topic_score_gemma":0.002264879,"domain_scores_codex":[0.9992151,0.0004982214,0.00003599408,0.00008751864,0.00005443767,0.0001087101],"domain_scores_gemma":[0.9989185,0.0002767128,0.0001312946,0.00008398998,0.00006355182,0.0005258769],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7667701,0.1559481,0.005153052,0.000438311,0.0007632821,0.000355237,0.0003193518,0.00182684,0.02055246,0.0002760674,0.001995436,0.04560177],"study_design_scores_gemma":[0.7078514,0.2859528,0.003201841,0.00001512516,0.0001323123,0.000102924,0.00003391598,0.0006228086,0.001064061,0.0001013449,0.0009078343,0.00001372976],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934198,0.0008038466,0.000438597,0.0002529039,0.0001003678,0.003501008,0.0004322146,0.00004659329,0.001004555],"genre_scores_gemma":[0.988665,0.0009944221,0.002126458,0.0008136293,0.0001773166,0.004234736,0.001214526,0.00002134507,0.001752535],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003256131,"threshold_uncertainty_score":0.01574427,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02703734848630878,"score_gpt":0.349479766187289,"score_spread":0.3224424177009803,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}